Andrew Kompa

BSc(Hons), GradDip(Drug Eval & Pharm Sci), PhD

Research Fellow

Contact details

Andrew is a Research Fellow with the CCRE in Therapeutics in this Department. Andrew completed his PhD in pharmacology, focusing on beta-adrenergic receptor signaling in cardiovascular disease at The University of Melbourne. His postdoctoral research then led him to Monash University investigating angiotensin and relaxin receptor signaling pathways in cardiac disease.

In 2002, Andrew joined the CCRE in therapeutics with interests in studying the processes involved in cardiac remodeling using in vivo and in vitro models of cardiac disease, with particular interests in developing clinically relevant agents for the treatment of heart failure.